featured
Cardiorenal Outcomes of Empagliflozin in Patients With HFpEF Across the BMI Spectrum
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: Principal findings and meta-analysis with the DELIVER trial
Eur. J. Heart Fail 2024 Apr 01;26(4)900-909, N Sattar, J Butler, MMY Lee, J Harrington, A Sharma, F Zannad, G Filippatos, S Verma, JL Januzzi, JP Ferreira, SJ Pocock, E Pfarr, AP Ofstad, M Brueckmann, M Packer, SD AnkerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.